バイオシミラー

Generics Bulletin: ジェネリック＆バイオシミラーニュース

India Biosimilars Landscape

12 Oct 2021

India leads the ways with the highest number of approved biosimilars.

Topic clinical-trials biosimilars

Generics Bulletin: ジェネリック＆バイオシミラーニュース

Coherus Is Confident After US Ranibizumab Filing

By Aidan Fry 27 Nov 2020

Having seen its development partner Bioeq file with the FDA in December last year, Coherus is confident that it will be a leader in the US biosimilar ranibizumab market targeting Lucentis.

Topic biosimilars deal-trends

Generics Bulletin: ジェネリック＆バイオシミラーニュース

Celltrion's Remsima SC Ready For Early 2020 Launch

By David Wallace 27 Nov 2020

Celltrion says it is ready to roll out its Remsima SC subcutaneous infliximab in Europe in the first quarter of 2020, after receiving a formal pan-European marketing authorization from the European Commission.

Topic biosimilars Launches Regulation

ターゲット市場の実像をつかむ

The evolving landscape of biosimilars

27 Nov 2020

It is important to understand how the biosimilar market has developed over the past five years. Take a look at some of the key events here.

Topic biosimilars

Generics Bulletin: ジェネリック＆バイオシミラーニュース

Alberta Is Second Canadian Province To Switch To Biosimilars

By David Wallace 27 Nov 2020

Alberta has become the second Canadian province to announce a biosimilar switching program, following the example set by British Columbia earlier this year. The move has been welcomed by Biosimilars Canada but criticized by originator-backed body Crohn’s and Colitis Canada.

Topic biosimilars Regulation

Generics Bulletin: ジェネリック＆バイオシミラーニュース

Pfizer Reports 80% Biosimilars Growth In Q3

By Akriti Seth 17 Nov 2020

Pfizer has reported 80% growth in its global biosimilars business for the third quarter of 2020, on the back of recent oncology launches. Though the company’s sterile injectables saw a slight drop in business, Pfizer’s biopharma business saw 4% growth.

Topic Coronavirus biosimilars deal-trends

世界の薬事規制動向＆情報を配信

Germany Sets Direction Of Travel With New Biosimilar Guidelines

21 Sep 2020

Germany is for the first time to adopt national guidelines on prescribing biologics and biosimilars in move towards increasing biosimilar uptake.

Topic EU biosimilars

Sitetrove: 治験責任医師と治験施設情報のデータベース

UK Sees PIP Codes Expand To Cover Hospital Drugs

By C+D Data 09 Sep 2020

Chemist + Druggist has expanded its “PIP code” system for UK pharmacy procurement to also encompass hospital drugs.

Topic biopharmaceutical Regulation biosimilars

Generics Bulletin: ジェネリック＆バイオシミラーニュース

Top 50 Generics and Biosimilars Companies

07 Sep 2020

The Annual Top 50 Generics & Biosimilars Companies League Table is here, and Generics Bulletin is sharing its content with you! Connect to league tables and commentary summarizing key developments for the Top 10 companies in generics and biosimilars, part of Generics Bulletin’s annual Top 50 ranking.

Topic biosimilars